Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
NCT07283887Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of romosozumab in osteoporosis, sponsored by National Taiwan University Hospital. Started Dec 2025; status: recruiting.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07283887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07283887.